Why Most Total Contact Cast Kits Face Backorders

Why Most Total Contact Cast Kits Face Backorders – And Why M-Med Never Does (We Do This Exclusively)

In 2026, clinicians still struggle with TCC kit shortages from major brands—while M-Med ships the same day. Here's why:

In the world of wound care, total contact casting (TCC) continues to be the gold standard for offloading diabetic foot ulcers (DFUs), supported by decades of evidence and IWGDF guidelines. Yet in early 2026, many clinicians are facing the same frustrating reality: TCC kits from major brands are frequently on backorder, delaying treatment for patients who simply cannot wait.

So why are these specialized kits so hard to get right now?

Several factors are converging to create persistent supply constraints.

First, global supply chains remain unstable. Tariffs, trade disruptions, logistics bottlenecks, and shortages of key materials—such as fiberglass, plaster, and specialty padding—continue to affect medical device manufacturing. While these issues aren't unique to TCC, they hit specialized products especially hard.

Second, demand for TCC has increased as more providers recognize the importance of effective offloading, but production capacity has not kept pace. For many large manufacturers, TCC kits represent only a tiny fraction of their overall business—often less than 1–5% of revenue. When resources or materials become limited, these low-volume, low-margin items are deprioritized. Production planning, inventory allocation, and supply chain attention naturally shift toward higher-turnover products like general dressings or compression therapy.

Third, regulatory and reimbursement changes add complexity. Recent CMS policy updates around skin substitutes, wound care products, and payment structures (including LCD reviews) may indirectly influence how manufacturers prioritize inventory and production schedules for offloading devices.

Finally, the niche nature of the market plays a role. TCC is a highly specialized, low-volume product compared to everyday wound care supplies. When raw material costs rise or supply chains tighten, manufacturers tend to focus on more profitable, higher-demand lines, leaving TCC kits at the back of the queue.

The result is predictable: clinicians often wait 2–8 weeks (or longer) for delivery. Some resort to sourcing kits on Amazon, using less effective alternatives, or delaying treatment—none of which is ideal for patient outcomes.

Fortunately, not every supplier is affected the same way.

M-Med takes a different approach. Total contact casting is not a small side product for us—it is our entire business. Because we focus exclusively on TCC, we monitor stock levels daily, forecast demand tightly, and prioritize production and ordering to ensure consistent availability. That specialization allows us to avoid the corporate bottlenecks and competing priorities that slow down larger, diversified manufacturers.

As of March 3, 2026, M-Med's Total Contact Cast System (Mobility Series) remains reliably in stock with no backorders. Kits ship quickly, include all necessary components (fiberglass rolls, plaster bandage, comfort foot plate, walking heel, instructions), and support consistent, evidence-based offloading without unnecessary delays.

If supply reliability is important to your practice, here are two straightforward ways to get TCC kits now:

• Order direct from our website: https://m-medusa.com/buynow/
• Purchase on Amazon: https://www.amazon.com/dp/B07GMSVRSW